Community pharmacists in Durham are to take part in a trial which will examine how the condition of patients with asthma is affected by monitoring by pharmacists.
|
Monitoring of asthma patients by pharmacists is to be compared with monitoring by GPs |
The second group would be seen by their GPs every two months. Both groups would be asked to record peak expiratory flow rates (PEFRs) twice daily.
The study is to run for 12 months and the effect on patients of pharmacist interventions will be assessed by looking at the number of GP visits, hospital admissions, time off work, PEFR scoring and medication compliance. Other factors which are to be taken into consideration are drug wastage, respiratory infections, exercise and allergic conditions.
The pharmacists who will be taking part in the trial are to undertake a training course organised by Dr Labib Tadros (lead clinical pharmacist, Darlington Memorial hospital). The hospital plans to make the asthma course available to other pharmacists later this year. Details of the pharmacist asthma management guidelines can be obtained from the pharmacy department at Darlington memorial hospital on 01325 743477.